Chrysa Mineo
CIK 1575644 · SVP, Corporate Development · last filed 2026-01-07
Chrysa Mineo is a SVP, Corporate Development who has filed 18 SEC Form 4 insider transactions across 2 companies since 2013. The most recent filing shows the insider disposed of $735.4K of CDTX on Jan 7, 2026. Across all open-market trades the lifetime net is −$3.2M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
18
-$3.22M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Cidara Therapeutics, Inc. (CDTX) Delisted | Director | 0 | $221.38 | $0 | $73.9K | 12 | 2026-01-07 |
| Receptos, Inc. (RCPT) Delisted | SVP, Corporate Development | 0 | — | — | -$3.29M | 6 | 2015-08-27 |
Recent Filings
18 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-07 | Cidara Therapeutics, Inc. (CDTX) Delisted | Disp (D) | −3,320 | -$735.4K | EDGAR |
| 2025-06-18 | Cidara Therapeutics, Inc. (CDTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-06-04 | Cidara Therapeutics, Inc. (CDTX) Delisted | Buy (P) | +3,320 | $73.9K | EDGAR |
| 2024-12-19 | Cidara Therapeutics, Inc. (CDTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-07-19 | Cidara Therapeutics, Inc. (CDTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-23 | Cidara Therapeutics, Inc. (CDTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-24 | Cidara Therapeutics, Inc. (CDTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-24 | Cidara Therapeutics, Inc. (CDTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-25 | Cidara Therapeutics, Inc. (CDTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-06-27 | Cidara Therapeutics, Inc. (CDTX) Delisted | Grant (A) | — | $0 | EDGAR |